Olanzapine and Breo ellipta drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Olanzapine (olanzapine) and Breo ellipta (fluticasone furoate; vilanterol trifenatate). Common drug interactions include chest discomfort among females and psychotic disorder among males.
The phase IV clinical study analyzes what interactions people have when they take Olanzapine and Breo ellipta. It is created by eHealthMe based on reports of 147 people who take the same drugs from the FDA, and is updated regularly.
What is Olanzapine?
Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.
What is Breo ellipta?
Breo ellipta has active ingredients of fluticasone furoate; vilanterol trifenatate. It is often used in asthma. eHealthMe is studying from 37,362 Breo ellipta users. Check the latest studies of Breo ellipta.
147 people who take Olanzapine and Breo ellipta together, and have interactions are studied.
What are the common drug interactions of Olanzapine and Breo ellipta, by gender? *
What are the common drug interactions of Olanzapine and Breo ellipta, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Olanzapine and Breo ellipta?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Olanzapine (69,242 reports)
- Breo ellipta (37,362 reports)
Browse all drug interactions of Olanzapine and Breo ellipta:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Olanzapine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Breo ellipta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Olanzapine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Breo ellipta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on olanzapine and fluticasone furoate; vilanterol trifenatate (the active ingredients of Olanzapine and Breo ellipta, respectively), and Olanzapine and Breo ellipta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Vytorin and Xarelto - 6 seconds ago
- Could L-Lysine cause High Blood Cholesterol? - 7 seconds ago
- Could Ifosfamide cause Angioedema? - 17 seconds ago
- Drug interactions of Losartan Potassium and Xyrem - 19 seconds ago
- Metastases To Bone and Blood Chloride Decreased - 21 seconds ago
- Could Bactroban cause Osteoarthritis? - 23 seconds ago
- Drug interactions of Naloxone Hydrochloride and Lidocaine - 50 seconds ago
- Could Propecia cause Psoriasis? - 54 seconds ago
- Could Remicade cause Morbid Thoughts? - 58 seconds ago
- Drug interactions of Palonosetron Hydrochloride and Lenvatinib - a minute ago